(Q28217168)

English

The antituberculosis drug ethionamide is activated by a flavoprotein monooxygenase

scientific article (publication date: 12 April 2002)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

The antituberculosis drug ethionamide is activated by a flavoprotein monooxygenase (English)

0 references

main subject

ethionamide S-oxide

1 reference

stated in

ChEBI release 2020-05-28

1 reference

Tommaso A Vannelli

1

0 references

Alina Dykman

series ordinal

2

0 references

Paul R Ortiz de Montellano

series ordinal

3

0 references

language of work or name

English

0 references

publication date

12 April 2002

0 references

published in

Journal of Biological Chemistry

0 references

volume

277

0 references

page(s)

12824-9

0 references

issue

15

0 references

cites work

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1074%2FJBC.M110751200

retrieved

21 January 2018

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1074%2FJBC.M110751200

retrieved

21 January 2018

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1074%2FJBC.M110751200

retrieved

21 January 2018

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1074%2FJBC.M110751200

retrieved

21 January 2018

Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1074%2FJBC.M110751200

retrieved

21 January 2018

Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1074%2FJBC.M110751200

retrieved

21 January 2018

Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1074%2FJBC.M110751200

retrieved

21 January 2018

Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1074%2FJBC.M110751200

retrieved

21 January 2018

Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1074%2FJBC.M110751200

retrieved

21 January 2018

Activation of the pro-drug ethionamide is regulated in mycobacteria

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1074%2FJBC.M110751200

retrieved

21 January 2018

Identifiers

DOI

10.1074/JBC.M110751200

0 references

PubMed ID

11823459

0 references

(Q28217168)

The antituberculosis drug ethionamide is activated by a flavoprotein monooxygenase

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)